These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


175 related items for PubMed ID: 1097109

  • 1. Quantitative immunofluorescence studies of the tumor antigen-bearing cell in giant cell tumor of bone and osteogenic sarcoma.
    Byers VS, Levin AS, Johnston JO, Hackett AJ.
    Cancer Res; 1975 Sep; 35(9):2520-31. PubMed ID: 1097109
    [Abstract] [Full Text] [Related]

  • 2. Antigenic differences among osteogenic sarcoma tumor cells taken from different locations in human tumors.
    Byers VS, Johnston JO.
    Cancer Res; 1977 Sep; 37(9):3173-83. PubMed ID: 69491
    [Abstract] [Full Text] [Related]

  • 3. [Generation and characterization of monoclonal antibody GCF-5 to human giant cell tumor of bone].
    Zhou L.
    Zhonghua Wai Ke Za Zhi; 1993 Feb; 31(2):79-81. PubMed ID: 8223010
    [Abstract] [Full Text] [Related]

  • 4. Differential antigenic expression of the DBA/2 lymphoma L1210 and its sublines: cross-reactivity with C3H mammary tumors as defined by syngeneic monoclonal antibodies.
    Rapp L, Fuji H.
    Cancer Res; 1983 Jun; 43(6):2592-9. PubMed ID: 6342755
    [Abstract] [Full Text] [Related]

  • 5. Serologic analysis of human tumor antigens. II. Reactivity of sera from eleven osetogenic sarcoma patients against autologous and allogeneic tumor cells.
    Rosenberg SA, Tondreau SC, Shoffner PC, Hyatt C, Brown JM, Thorpe W, Sindelar W.
    Surgery; 1979 Aug; 86(2):258-65. PubMed ID: 288177
    [Abstract] [Full Text] [Related]

  • 6. Immunohistochemical study of mononuclear phagocyte antigens in giant cell tumor of bone.
    Brecher ME, Franklin WA, Simon MA.
    Am J Pathol; 1986 Nov; 125(2):252-7. PubMed ID: 3789086
    [Abstract] [Full Text] [Related]

  • 7. Transforming growth factor alpha and CD68 immunoreactivity in giant cell tumours of bone: a study on the nature of stromal and giant cells, and their interrelations.
    Hasegawa T, Hirose T, Seki K, Sano T, Hizawa K.
    J Pathol; 1993 Jul; 170(3):305-10. PubMed ID: 7907656
    [Abstract] [Full Text] [Related]

  • 8. Immunofluorescence tests on sera of patients with osteogenic sarcoma.
    Priori ES, Wilbur JR, Dmochowski L.
    J Natl Cancer Inst; 1971 Jun; 46(6):1299-308. PubMed ID: 4932429
    [No Abstract] [Full Text] [Related]

  • 9. Hematogenous micrometastases in osteosarcoma patients.
    Bruland OS, Høifødt H, Saeter G, Smeland S, Fodstad O.
    Clin Cancer Res; 2005 Jul 01; 11(13):4666-73. PubMed ID: 16000559
    [Abstract] [Full Text] [Related]

  • 10. Detection of a human sarcoma-associated antigen with monoclonal antibodies.
    Brown JM.
    Cancer Res; 1983 May 01; 43(5):2113-20. PubMed ID: 6299540
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Human natural immunoglobulin M antibodies induce apoptosis of human neuroblastoma cells by binding to a Mr 260,000 antigen.
    David K, Ollert MW, Vollmert C, Heiligtag S, Eickhoff B, Erttmann R, Bredehorst R, Vogel CW.
    Cancer Res; 1999 Aug 01; 59(15):3768-75. PubMed ID: 10446994
    [Abstract] [Full Text] [Related]

  • 13. An immunohistological study of giant-cell tumour of bone: evidence for an osteoclast origin of the giant cells.
    Athanasou NA, Bliss E, Gatter KC, Heryet A, Woods CG, McGee JO.
    J Pathol; 1985 Nov 01; 147(3):153-8. PubMed ID: 4067733
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Delineation of four cell types comprising the giant cell tumor of bone. Expression of Ia and monocyte-macrophage lineage antigens.
    Burmester GR, Winchester RJ, Dimitriu-Bona A, Klein M, Steiner G, Sissons HA.
    J Clin Invest; 1983 Jun 01; 71(6):1633-48. PubMed ID: 6575016
    [Abstract] [Full Text] [Related]

  • 18. Recovery of stromal stem cells in bone sarcoma patients after chemotherapy: implication for cell-based therapy in bone defect reconstruction.
    Beccheroni A, Lucarelli E, Donati D, Sangiorgi L, Capponcelli S, Gorini M, Zambon Bertoja A, Giardino R, Mercuri M, Ferrari S, Bacci G, Picci P.
    Oncol Rep; 2003 Jun 01; 10(4):891-6. PubMed ID: 12792741
    [Abstract] [Full Text] [Related]

  • 19. Monoclonal antibody to a human osteogenic sarcoma cell line.
    Lizonová A, Blahová S, Bízik J, Grófová M.
    Arch Geschwulstforsch; 1988 Jun 01; 58(3):151-7. PubMed ID: 3046555
    [Abstract] [Full Text] [Related]

  • 20. [In vitro immune response of patient lymphocytes to live autologous tumor cells].
    Grigor'eva MP, Kosmiadi GA, Govallo VI.
    Vopr Onkol; 1980 Jun 01; 26(9):8-11. PubMed ID: 7423909
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 9.